Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell‐derived thyroid carcinoma
Mona M. Sabra; Eric J. Sherman; R. Michael Tuttle
Author Information: Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill‐Cornell College of Medicine
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.